Surgery Partners, Inc. reported second quarter 2026 results on August 10, 2026, with revenue increasing 2.7% year-over-year to $848.9 million and same-facility revenues rising 5.0%. The company posted a net loss attributable to Surgery Partners of $15.0 million, compared to a $2.5 million loss in the prior year period, while Adjusted EBITDA decreased slightly to $125.2 million from $129.0 million. Management reaffirmed full-year 2026 revenue guidance of $3.35 billion to $3.45 billion and Adjusted EBITDA of at least $530 million, excluding the impact of a pending divestiture in Idaho Falls. The company reported cash and cash equivalents of $216.7 million and a net debt-to-EBITDA ratio of approximately 4.4x as of June 30, 2026. Surgery Partners operates as a leading owner and operator of short-stay surgical facilities and healthcare services in the United States.